Effect of NAC on decreased MYH expression caused by arecoline in C2C12 cells. by Yi-Xuan Li (6633845)

Decreased osteoclast formation by LDH-A or LDH-B depletion. by Heejin Ahn (3173670)

Knockdown of ATP2C1 results in a minor decrease of [Ca²⁺] in WPB. by Julian Terglane (12975565)

Subjects:

Intracellular PI3P was decreased in a p38 MAPK-dependent manner in Db cells. by Fumi Kano (139125)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

CMV infection decreases TER of polarized HCoEpiC. by Ekaterina Maidji (3797899)

Overexpression of Tdp2 was associated with a decrease in HBV CCC DNA. by Xiuji Cui (755449)

Lumcorin decreases melanoma growth. by Katarzyna Pietraszek (113579)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

Resveratrol decreased nitrite production. by André Quincozes-Santos (108426)

VPA decreases cell proliferation. by Muriel Rhinn (406515)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

HDAC inhibition by quisinostat synergizes with proteasome inhibition to decrease synovial sarcoma cell viability. by Aimée N. Laporte (3617987)

Subjects:

miR-200c decreases KLOTHO expression in HK-2 cells by translational repression. by Kenichi Morii (6843554)

Activation of PAR2 decreased the frequency of mEPSCs. by Petra Mrozkova (3226530)

“…<b>(C)</b> Application of SLIGKV-NH₂ (100 μM, 4 min) decreased the mEPSC frequency (n = 17; ***p < 0.001) compared to the pretreatment period (100%). …”

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

“…<p>Immunohistochemistry (IHC) of brain sections through the (A) cerebellum and (B) hippocampus in infected and uninfected mice reveal that (A) while we observed no difference in cerebellar PrP^Res accumulation among infected untreated, non-responder or responder mice, both GFAP stain intensity, a measure of astrogliosis, and vacuolation, a hallmark of prion-mediated neurodegeneration, were significantly decreased in LSPC responder mice. …”

The stimulation with FA or GW501516 decreases DNA damage. by Shota Tanaka (339198)